Key Details
Price
$8.83Annual Revenue
$79.20 MAnnual EPS
-$6.38Annual ROE
-49.74%Beta
1.20Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 27, 2024Recent annual earnings:
Nov 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $1.16. This compares to loss of $1.33 per share a year ago.
Enanta Pharmaceuticals (ENTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With RSV.
Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $1.07 per share versus the Zacks Consensus Estimate of a loss of $1.49. This compares to loss of $1.86 per share a year ago.
Enanta Pharmaceuticals (ENTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Enanta Pharmaceuticals (ENTA) reported a quarterly loss of $1.47 per share, which was higher than the Zacks Consensus Estimate of a loss of $1.26 per share. This is an improvement from the loss of $1.79 per share reported in the same quarter last year.
Enanta Pharmaceuticals, Inc. (ENTA) Q1 2024 Earnings Call Transcript
Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $1.58 per share versus the Zacks Consensus Estimate of a loss of $1.18. This compares to loss of $1.39 per share a year ago.
Enanta Pharmaceuticals (ENTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Enanta Pharmaceuticals (ENTA), OneConnect Financial. (OCFT), KNOT Offshore (KNOP), Hippo Holdings (HIPO) and H World Group (HTHT) could surprise investors with big returns this Christmas.
FAQ
- What is the primary business of Enanta Pharmaceuticals?
- What is the ticker symbol for Enanta Pharmaceuticals?
- Does Enanta Pharmaceuticals pay dividends?
- What sector is Enanta Pharmaceuticals in?
- What industry is Enanta Pharmaceuticals in?
- What country is Enanta Pharmaceuticals based in?
- When did Enanta Pharmaceuticals go public?
- Is Enanta Pharmaceuticals in the S&P 500?
- Is Enanta Pharmaceuticals in the NASDAQ 100?
- Is Enanta Pharmaceuticals in the Dow Jones?
- When was Enanta Pharmaceuticals's last earnings report?
- When does Enanta Pharmaceuticals report earnings?
- Should I buy Enanta Pharmaceuticals stock now?